Dynamics of Epicardiac Fat and Heart Function in Type 2 Diabetic Patients Initiated with SGLT-2 Inhibitors
Adina Braha,1 Bogdan Timar,2 Laura Diaconu,3 Raluca Lupusoru,1,4 Lucian Vasiluta,3 Alexandra Sima,3 Adrian Vlad,3 Mircea Munteanu,3 Alin Albai,3 Daniela Cipu,5 Romulus Timar3 1First Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Ro...
Enregistré dans:
Auteurs principaux: | Braha A, Timar B, Diaconu L, Lupusoru R, Vasiluta L, Sima A, Vlad A, Munteanu M, Albai A, Cipu D, Timar R |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/85ee4e7ff5a14fa3ab131154bc6a81b8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
par: Zheng,Huan, et autres
Publié: (2014) -
Increased Arterial Stiffness Is Associated With Reduced Diastolic Function in Youth With Obesity and Type 2 Diabetes
par: Nicolas L. Madsen, et autres
Publié: (2021) -
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity
par: Nataliia V. Blinova, et autres
Publié: (2021) -
Consensus Defined Diastolic Dysfunction and Cardiac Postoperative Morbidity Score: A Prospective Observational Study
par: Bonnie Kyle, et autres
Publié: (2021) -
Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
par: Albai O, et autres
Publié: (2020)